Why Did Vertex Pharmaceuticals Stock Fall On Tuesday?

benzinga.com/25/05/45236530/vertex-q1-earnings-slide-as-sales-fall-short-of-forecasts

On Monday, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) reported lower-than-expected first-quarter 2025 earnings.
Vertex reported first-quarter adjusted earnings per share of $4.06, down from $4.76 a year ago, missing the consensus of $4.32.
The cystic fibrosis-focused company…

This story appeared on benzinga.com, 2025-05-06 20:28:44.
The Entire Business World on a Single Page. Free to Use →